Undiscovered Gems in Global Markets for July 2026
As global markets navigate the complexities of Middle East tensions and energy market volatility, small-cap stocks have shown mixed performances, with the Russell 2000 Index experiencing a slight decline amid broader market fluctuations. In this environment, identifying undiscovered gems requires a keen eye for companies with strong fundamentals and innovative potential that can thrive despite economic uncertainties.
Top 10 Undiscovered Gems With Strong Fundamentals Globally
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| CNMC Goldmine Holdings | 0.84% | 32.52% | 78.36% | ★★★★★★ |
| DeHua TB New Decoration MaterialLtd | 0.63% | 1.50% | 2.14% | ★★★★★★ |
| Beijing Chunlizhengda Medical Instruments | NA | -2.67% | -10.59% | ★★★★★★ |
| Nippon Carbide Industries | 16.74% | 1.99% | -4.81% | ★★★★★★ |
| Base | NA | 11.66% | 17.63% | ★★★★★★ |
| GROUPE SFPI | 18.02% | 4.25% | -29.76% | ★★★★★★ |
| Zhejiang Jolly PharmaceuticalLTD | 21.31% | 17.83% | 29.70% | ★★★★★☆ |
| Sing Investments & Finance | 0.15% | 7.06% | 8.65% | ★★★★☆☆ |
| Shengda ResourcesLtd | 54.08% | 7.99% | 3.75% | ★★★☆☆☆ |
| Regina Miracle International (Holdings) | 132.81% | 0.48% | -15.87% | ★★★☆☆☆ |
Let's review some notable picks from our screened stocks.
AcadeMedia (OM:ACAD)
Simply Wall St Value Rating: ★★★☆☆☆
Overview: AcadeMedia AB (publ) is an independent education provider operating in Sweden, Finland, Norway, the Netherlands, and Germany with a market capitalization of approximately SEK9.99 billion.
Operations: Revenue streams for AcadeMedia come primarily from its Preschool & International segment (SEK8.11 billion), Upper Secondary Schools (SEK6.77 billion), and Compulsory School (SEK4.98 billion). Adult Education contributes SEK2 billion, while adjustments account for a reduction of SEK2.11 billion in total revenue calculations.
AcadeMedia, a promising player in the education sector, has shown robust financial health with earnings growing 19.1% over the past year and trading at 45.5% below its estimated fair value. The company's net debt to equity ratio stands at a satisfactory 22.7%, reflecting prudent financial management as it expands internationally, particularly in Germany where it operates 107 preschools and plans for more growth. However, its EBIT covers interest payments only 2.7 times, indicating some risk in debt coverage. Recent results highlight sales of SEK 5,371 million for Q3 with net income rising to SEK 290 million from SEK 241 million last year.
Shanghai Allist Pharmaceuticals (SHSE:688578)
Simply Wall St Value Rating: ★★★★★★
Overview: Shanghai Allist Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research and development of tumor-targeted drugs in China and internationally, with a market cap of CN¥53.17 billion.
Operations: Allist Pharmaceuticals generates its revenue primarily from the research and development of drugs, amounting to CN¥5.67 billion. The company's financial performance is characterized by a focus on this core segment, reflecting its strategic emphasis in the pharmaceutical industry.
Shanghai Allist Pharmaceuticals seems to be making waves with its strategic moves and financial performance. Recently, it entered a collaboration with TransThera Sciences for a Phase II clinical trial, showcasing its commitment to innovation in cancer treatment. The company reported impressive first-quarter earnings of CNY 636.04 million, up from CNY 410.5 million last year, with basic earnings per share rising to CNY 1.41 from CNY 0.91. Trading at an attractive valuation—52% below estimated fair value—Allist also boasts high-quality earnings and zero debt, highlighting its strong position in the pharmaceutical industry landscape.
NSD (TSE:9759)
Simply Wall St Value Rating: ★★★★★★
Overview: NSD Co., Ltd. is a Japanese company that offers a range of IT solutions, with a market capitalization of approximately ¥205.67 billion.
Operations: The company's revenue primarily stems from its System Development Business, with notable contributions from Financial IT at ¥35.07 billion and Industrial IT at ¥28.29 billion. The Solution Business adds ¥17.72 billion to the overall revenue mix.
NSD, a company with no debt, has demonstrated robust financial health. Over the past five years, earnings have grown at an impressive rate of 12.7% annually. Despite not outpacing the IT industry last year with a 10.3% growth compared to the industry's 13.1%, NSD remains appealing as it trades at 37.6% below its estimated fair value and boasts high-quality earnings. Recently, NSD repurchased shares worth ¥558 million and reported net sales of ¥9,786 million for May 2026, up from ¥8,922 million in May 2025, indicating solid revenue generation capabilities amidst ongoing market dynamics.
- Navigate through the intricacies of NSD with our comprehensive health report here.
Review our historical performance report to gain insights into NSD's's past performance.
Taking Advantage
- Navigate through the entire inventory of 145 Global Undiscovered Gems With Strong Fundamentals here.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com